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ABSTRACT
The west Africa sub‑region, notably Nigeria, records the highest twin and triplet birth rates globally. Therefore, the time has 
come for attention to be focused on an area of gemellology, feto‑fetal transfusion syndromes in multiplets, in order to attend 
to what the authors consider a yet‑to‑be‑explored major significant contributor to the overall unacceptably high fetal, perinatal 
and neonatal losses in the region. This review examines the genetics, embryology and pathophysiology of twinning in general 
to provide the background to the spectrum of clinical presentations of feto‑fetal transfusion syndromes. Twin‑to‑twin transfusion 
syndromes (TTTS) are unique prenatal complications of monochorionic multiplets and manifest as twin oligohydramnios 
polyhydramnios sequence (TOPS), twin anaemia polyhydramnios sequence (TAPS) and twin reversed arterial perfusion 
syndrome (TRAPS). These grave complications are associated with fetal malformations and early miscarriages as well as 
fetal weight and haemoglobin discordances, discordant haemodynamic changes in addition to intrauterine deaths, perinatal 
asphyxia, cerebral palsy and brain damage. Most importantly, the management of TTTS requires highly skilled interventions, 
expensive equipment, rare expertise and costly treatment options that are currently not available in Nigeria and other developing 
countries. Moreover, these management options are unavailable in Nigeria because considerable attention of the health 
system is directed at the burden of high levels of maternal, perinatal, and childhood morbidity and mortality. Regardless of 
these overwhelming obstetric and paediatric challenges, there is still urgent need to develop feto‑maternal medicine units in 
the country to focus attention on the management of TTTS because of high twinning rate and attending fetal, perinatal and 
neonatal wastages. Furthermore, Nigeria is now witnessing an increased incidence of twin births from the rapidly developing 
assisted reproductive therapy centres in the country. All these provide justification for devoting attention to this unique area of 
perinatal care that will, on balance, be robustly cost effective. Hence, this review of transfusion syndromes in monochorionic 
multiplets aims to sensitize health workers and researchers in Nigeria, particularly perinatologists and feto‑maternal physicians, 
neonatal paediatricians, as well as policy makers and other stakeholders, on the need to focus attention on the problem.
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Introduction
The human uterus is probably modeled naturally for the nurture 
of one fetus per pregnancy, and this possibly explains why 
most pregnancies end up as singletons.[1] Some pregnancies, 
nevertheless, produce multiplets resulting in two or more 
fetuses. For this reason, it is not surprising that pregnancies 
with more than one fetus are frequently associated with 
complications,[2‑6] such as miscarriages, pre‑term pre‑labour 
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rupture of membranes (PPROM), preterm births, low birth 
weights as well as antepartum haemorrhage and hypertension 
in addition to twin‑to‑twin transfusion syndromes (TTTS) 
including twin anaemia polycythemia sequence (TAPS), TTTS 
and twin reversed arterial perfusion syndrome (TRAPS).
These complications demand skilled management in order to 
achieve successful perinatal outcomes.[5,6] At present, these 
specialized skills are not readily available in Nigeria and 
other developing countries because of high cost of setting 
up centres for fetal and perinatal care.[7] Consequently, a 
ready excuse for failure to develop this highly technical and 
expensive branch of perinatal care is the preponderance of 
other medical problems, such as infections and infestations 
in the newborn[8] and major obstetric complications including 
obstructed labour, obstetric haemorrhage, hypertensive 
diseases, illicit abortions, and puerperal genital sepsis.[9,10] 
These health hazards, all causes of very high perinatal 
and maternal mortality, tend to divert health institutions’ 
attention from the development of desired skilled fetal 
medicine units.
It is, therefore, against this backdrop that we must consider 
the importance of the subject of transfusion syndromes in 
multiplets with reference to developing countries, notably 
Nigeria that records the world’s highest twinning rate. In 
1969, about 1 in 22 maternities in southwestern Nigeria 
were found to be twins. A 5‑year study on the frequency 
of twinning in a rural community (Igbo‑Ora) in western 
Nigeria, based on the analysis of data collected from an 
entire community, (population: 30000) in which there was no 
selection, was conducted by Nylander from 1964 to 1968.[11] 
In that landmark publication, Nylander reported a twinning 
rate of 45.1 per 1000 maternities, considered the highest to 
date globally.[11,12] The twinning and triplet rates in western 
Nigeria were found to be approximately 4 and 16 (i.e., 42) 
times the corresponding rates in the UK and USA.[12,13] 
Although a more recent study on a very small homogenous 
settlement, Candido Godoi in south Brazil, a municipality of 
approximately 6000 inhabitants, reported a twinning rate of 
10%, this does not negate the more statistically valid observed 
highest rate of 4.5% from western Nigeria.[14]
Moreover, Nigeria now witnesses an increasing spate of 
assisted reproductive therapy (ART) in many health centres.[15] 
Spontaneous twins comprise one‑third monochorionic (MC) 
twin pairs; iatrogenic twins (after ART assisted infertility 
treatment) double the overall twinning rate, and include, 
even if a smaller proportion (5%), of MC twin pairs.[16] These 
considerations must impact the overall MC twinning rate in 
Nigeria.
The implications of increased multiple pregnancy rate 
are worrisome and include increased early pregnancy 
losses, sometimes even prior to pregnancy detection; 
late miscarriages; preterm births, with implied perinatal 
morbidity/mortality; infant morbidity/mortality; late 
morbidity/mortality, with implied socioeconomic burden 
to parents, relatives, and governments. Therefore, all these 
provide justification for devoting attention to this unique 
area of perinatal care that will, on balance, be robustly cost 
effective. As a result, this review of transfusion syndromes in 
monochorionic multiplets aims to sensitize health workers 
and researchers in Nigeria, particularly perinatologists and 
feto‑maternal physicians, neonatal paediatricians, as well as 
policy makers and other stakeholders, on the need to focus 
attention on the problem.
Singletons and Multiplets
Singletons
A normal pregnancy producing a singleton is the result of 
the fertilization of a normal ovum and a structurally intact 
spermatozoon leading to the formation of a zygote.[1] The 
zygote subsequently undergoes further differentiation to 
form blastocyst that develops through different stages to 
the fetus. The fetus is attached by the umbilical cord to the 
placenta, embedded to the uterine wall and surrounded by 
the amniotic fluid. These structures are enclosed by two layers 
of membrane, an outer layer, chorion, and an inner layer, 
amnion. Singletons are, therefore, described as monozygotic, 
monochorionic and monoamniotic [Figures 1 and 2].[1]
Mechanism for the production of multiplets, zygote 
cleavage and chorionicity
The mechanisms for the production of twins are not well 
understood. While dizygotic twin results from fertilization of 
Figure 1: Zygocity and chorionicity; impact on fetal, perinatal, and neonatal 
outcome with late sequelae. (Liesbeth Lewi and Jan Deprest[16])
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two ova, it is reasoned that a monozygotic twin is the outcome 
of fertilization of an ovum followed by early cleavage into two 
halves that undergo further independent development.[2,3] 
Further, the time between fertilization and cleavage of the 
zygote is a determinant of the type of resultant twin. For this 
reason, a monozygotic twin may be either of the following: 
dichorionic, monochorionic diamniotic, monochorionic 
monoamniotic and conjoined following cleavage on the 1st, 
3rd, 9th and 12th days, respectively.[16] [Figures 1 and 2].
Frequency of multiplets
The overall incidence of multiple pregnancies on a global 
scale has witnessed a steady rise from 1 in 100 to 1 in 70 
births.[16] Moreover, there is a 40% and three‑fold increase, 
respectively, in twinning and higher order multiple births. 
In addition, the incidence of monozygotic twins on the 
other hand is 4 per 1000 births.[17] The explanation for 
the increasing frequencies is not clear but some identified 
factors include hereditary predisposition, commonly found 
in dizygotic twins, ethnicity, advanced maternal age as 
documented increase by 2% at 35 years. Other factors 
include increasing parity as documented increase by 2% after 
four pregnancies, ovulation induction with hormones, and 
five to ten‑fold increase in twining following ART, including 
blastocyst transfer, micromanipulations of the zona pellucida 
with intracytoplasmic sperm injection as well as assisted 
hatching.[18‑21]
Placentation
The placenta plays key roles in the survival of the fetus 
through the provision of nutrients, oxygenation and gaseous 
exchanges, fluid and electrolyte balance and excretion of 
nitrogenous waste products.[22] Hence, absence of placenta is 
not compatible with survival of a fetus. Therefore, every fetus 
is attached to a placenta for survival. As a result, singletons 
are attached to a placenta whereas multiplets attach to either 
one or more placentas depending on the chorionicity of the 
fetus.[16] In this regard, while dichorionic twins are attached 
to two placentas, monochorionic twins share one placenta. 
The sharing of a common placenta by monochorionic 
twins is fraught with complications because it is associated 
with the development of placental anastomoses between 
arterial and venous blood vessels of the twins as either 
arteriovenous (AV) or arterioarterial (AA) anastomoses.[1,16,23]
Several studies[24‑27] have demonstrated evidence from 
injection of dye into the placenta and visualization at 
fetoscopy, ultrasonography and Doppler velocimetry that 
vascular anastomoses occur predominantly in monochorionic 
twins complicated by twin‑to‑twin transfusion. This 
complication leads to dire consequences in the twins that 
include discordance in amniotic fluid volume, differential 
filling of the bladder, differential fetal growth and differential 
haemoglobin concentration.[16] In addition, observational 
studies by Senat et al.[28] have confirmed that such 
monochorionic twins are prone to increased incidence of 
low birth weight, neurodevelopmental impairment, cerebral 
palsy, renal and cardiovascular damage, perinatal death and 
death in infancy.
Sequence of events
The natural history of intertwin transfusions in multiplets 
reveals a wide range of disorders with different outcomes 
and progression from one stage to the next that are neither 
slow nor methodical or predictable but rather difficult to 
anticipate, can be sudden and may altogether skip stages.[29]
In multiplet transfusions, the donor and recipient fetuses 
make concerted efforts to maintain the body’s homeostasis 
but the effort is undermined by the ongoing imbalance in 
the transfusion of blood from one twin to the other. Hence, 
as pregnancy progresses, the vasculature of the anastomoses 
increase in diameter leading to increasing volumes of blood 
transfused from donor to recipient with worsening of disease 
as gestation advances. Deterioration of fetal condition can 
be seen clinically and by ultrasonic screening as follows. The 
earliest finding relates to amniotic fluid imbalance that is 
evident as an oligohydramnios‑polyhydramnios sequence. 
Then, a decreased donor and increased recipient urine 
output is noted by ultrasound as absence of donor bladder 
and enlarged recipient bladder. This observation is followed 
by alterations in blood flow in various vessels detected by 
Doppler velocimetry. Other changes that have been observed 
include growth restriction in the donor, cardiac dysfunction 
because of volume overload as well as hydrops fetalis of 
Figure 2: Chorionicity, amniosity, and conjoint twins. (Courtesy: van Vugt 
JMG, Shulman LP, Snijders RJM. Fetal Medicine Foundation, Netherlands, 
2006)
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the recipient and death of one or both fetuses.[16,29,30,31] The 
changes are summarized in Table 1.[1]
Twin‑twin‑transfusion syndrome
TTFS is the result of interfetal transfusion in monochorionic 
multiple pregnancies, occurring between 15 and 26 weeks 
of gestation.[31,32] Two patterns of interfetal transfusion in 
monochorionic multiple gestations have been described 
based on ultrasound studies. The most frequent pattern 
affects 90% of the cases and results from constant but 
balanced bidirectional interfetal transfusion between 
the twins.[16] This means that the transfusion from one 
twin (Baby 1 – donor) to the other (Baby 2 – recipient) is 
counterbalanced by the transfusion from Baby 2 (recipient) 
to Baby 1 (donor).
Conversely, in 10% of monochorionic twins, a chronic 
imbalance in net flow develops, resulting in TTTS,[32,33] and it 
brings about different complications in the twins. Whereas the 
donor develops hypovolaemia, oliguria and oligohydramnios, 
the recipient develops hypervolaemia, polyuria and 
polyhydramnios, circulatory overload and hydrops. The 
presence of hydramnios is detected at ultrasonic scan by 
the appearance of characteristic changes in the quantity of 
amniotic fluid contained in the sac. Thus, in the recipient 
there is polyhydramnios in its sac secondary to polyuria, 
demonstrated by the presence of a deep vertical pocket 
of ≥8 cm prior  to 20 weeks and ≥10 cm after 20 weeks’ 
gestation.[34‑36] On the other hand, the donor twin develops 
oliguria and oligohydramnios demonstrated with the deepest 
vertical pocket measuring ≤2 cm on ultrasound scan.[34]
Based on ultrasound and Doppler studies, Quintero et al.[37] 
have described five possible stages in the progression of TTTS. 
Accordingly, stage I is typified by presence of hydramnios in 
the recipient sac but the bladder is still visible. Stage II is 
underlined by empty bladder of the donor twin (stuck Twin). 
Stage III is characterized by severely abnormal Doppler 
studies including absent or reversed end‑diastolic flow in 
the umbilical artery or abnormal venous Doppler pattern in 
the recipient, such as reverse flow in the ductus venosus or 
pulsatile umbilical venous flow. Stage IV implies fetal hydrops 
and stage V corresponds to the death of one or both twins. 
The Quintero’s classification[37,38] has been criticized because 
the five stages do not correlate with either severity of disease 
or time‑scale for progressive deterioration of disease.[29] It has 
been observed that TTTS can present as stage III from the 
outset and stage I disease can progress to stage V without 
passing through stages II, III and IV. Furthermore, Lewi and 
Deprest[16] noted that this classification does not predict the 
outcome to treatment of all stages of TTTS. Hence, at best, 
the Quintero staging system reflects the different possible 
clinical manifestations that may result from a variable 
contribution of intertwin transfusion imbalance, hormonal 
factors and the degree of placental sharing. It should be noted 
that other conditions can also lead to growth discordance, 
thus confusing the picture presented by TTTS.[16] For example, 
in a twin gestation, oligohydramnios may be associated with 
a growth restricted twin that appears to be stuck, whereas 
polyhydramnios is absent in the larger baby. Likewise, the 
isolated presence of hydramnios in one sac with a normal 
amniotic fluid in the other certainly precludes a diagnosis 
of TTTS. Hence, multiplets that present with these features 
call for further assessment to identify the underlying cause 
of the discordance in fetal growth.
Pathophysiology
The pathology of feto‑fetal transfusion essentially consists 
of abnormal intertwin placental fetal vascular anastomoses, 
first described as ‘Chorioangiopagus Vessels’ by Friedrich 
Schatz in his study of monochorionic pregnancies between 
1875 and 1910.[1] These chorioangiopagus vessels described 
the placental vascular anastomoses, which were considered 
to be variant on the nomenclature used for the description 
of conjoined twins. Schatz suggested that the twins were 
connected by blood vessels, and this constituted the mildest 
form on the spectrum of what could be considered ‘the 
conjoint twin syndrome’.[39] In essence, the ‘conjoint twin 
syndrome’ literally spans a spectrum from ‘placental part 
sharing’ to ‘fetal body part sharing’ [Figures 2 and 3].
The exact pathophysiology of TTTS is not clear.[16] 
Nevertheless, diverse mechanisms,[40‑47] such as vascular 
anastomoses, haemodynamic and hormonal factors, have 
been proposed to explain the changes associated with the 
condition. It is for this reason that TTTS is now viewed to 
be more complex than just the simple transfer of blood from 
Table 1: Fetal effects of multiplet transfusion syndromes
(Courtesy: Skupski DW)
Oligohydramnios-polyhydramnios sequence (Amniotic fluid imbalance)
Decreased donor and increased recipient urine output, detected by ultrasound 
as absence and enlarged bladder in donor and recipient twins
Alterations of blood flow in various blood vessels based on Doppler velocimetry
Absent or reversed end-diastolic velocity of the umbilical artery in the donor 
twin
Pulsatile umbilical venous flow in the recipient twin
Absent or reversed diastolic velocity in the ductus venosus of the recipient twin
Growth restriction in the donor twin detected by estimated fetal weight 
determination by ultrasound
Cardiac dysfunction due to vascular volume overload in the recipient twin 
detected by fetal echocardiography
Hydrops fetalis of the recipient twin detected by ultrasound
Death of one or both foetuses
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one twin to the other. Thus, the development of TTTS is 
best explained on the basis of unique vascular anastomoses 
occurring in the placenta of monochorionic twins revealed 
by postnatal injection studies[36] and in‑vivo fetoscopic 
observations,[38,48] indicating the presence of at least one 
unidirectional AV anastomosis as an anatomical prerequisite 
for the development of TTTS. Thus, placental anastomoses 
can be AA, AV and venovenous (VV) [Figures 3 and 4].[16]
AA and VV anastomoses are typically superficial, bidirectional 
vascular connections on the surface of the chorionic plate, 
forming direct communications between the arteries and 
the veins of the two fetal circulations. The direction of flow 
depends on the relative interfetal vascular pressure gradients. 
AV anastomoses are referred to as ‘deep’ anastomoses 
because they occur at the capillary level deep within the 
depth of the placenta, receiving arterial supply from one 
twin and providing well‑oxygenated venous drainage to the 
other. Hence, the supplying artery and draining vein of the 
AV anastomoses can be visualized on the placental surface 
as an unpaired artery and vein that pierce the chorionic 
plate in close proximity to each other. The AV anastomoses 
allows flow in only one direction, and hence, may create an 
imbalance in interfetal transfusion leading to TTTS, unless 
balanced by an oppositely directed transfusion through other 
superficial or deep anastomoses. Hence, the presence of 
bidirectional AA anastomoses is believed to protect against 
the development of TTTS because most (84%) non‑TTTS 
monochorionic placentas have AA anastomoses in contrast 
to TTTS (20%).[34,36]
Sonographically distinct TTTS is defined in 75% of cases 
by haematocrit difference of less than 15%. Hence, it is apt 
to infer that other mechanisms may explain TTTS in the 
other 25% with inter twin haematocrit difference of more 
than 15%. It has also been noted that changes expected to 
accompany chronic transfusion in donor and recipient twins 
are absent in some cases of TTTS, thus signifying that other 
mechanisms should be invoked to explain the findings in 
multiplet transfusion. In this regard, elevated erythropoietin 
level is expected to be demonstrated in the donor, however, 
this is not the case in some cases of TTTS.[40] Moreover, iron 
depletion and overload are absent in the donor and recipient 
twin accordingly.[41]
By same token, various reports[42,43] have found that placental 
dysfunction is associated with an increased feto‑placental 
resistance that promotes the transfusion of blood from one 
twin (growth restricted) to the other (recipient). Therefore, 
the demonstration of decreased levels of hormones including 
insulin growth factor II[42] and Leptin[43] in donors as compared 
to values in the recipients suggests that the problem is 
discordant placental development rather than transfusion 
as cause of the discordance in growth. Furthermore, 
other hormonal changes occur in the recipient and donor 
twins involving the circulating levels of endothelin I, atrial 
natriuretic peptide and renin, as well as angiotensin and 
aldosterone.[44]
Endothelin I, a hormone derived from the vascular 
endothelium, is elevated in recipients and it leads to the 
development of peripheral vasoconstriction and hypertension. 
In addition, atrial natriuretic peptide, secreted by atrial 
myocytes, in response to filling of the atrium, is elevated 
in recipients leading to sodium and fluid excretion by the 
Figure 3: Monochorionic Monoamniotic Placental Angioarchitecture with 
Fetofetal Vascular Anastomoses; Macroscopic image of large diameter 
anastomoses and side‑to‑side insertion of umbilical cords. (Liesbeth Lewi 
and Jan Deprest)
Figure 4: Angiography displaying fetofetal vascular anastomoses. Diagnostic 
angiography in which injection of umbilical vessels of one twin was 
sufficient to visualize placental vascularization of both twins owing to 
presence of large arterioarterial and venovenous anastomoses. In addition, 
approximately 50% of the placenta consisted of shared cotyledons. (Liesbeth 
Lewi and Jan Deprest)
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kidneys of the affected twin. Moreover, there is an increased 
renin gene and protein in the donor kidney as compared 
to the recipient kidneys. These observations suggest the 
role of the renin‑angiotensin‑aldosterone mechanism in the 
development of TTTS.[45‑47] Thus, the pathophysiology of 
sonographically‑defined TTTS is most likely multifactorial 
with vascular anastomoses providing the anatomic basis, 
whereas haemodynamic and hormonal factors contribute in 
varying degrees to its clinical development.
Early detection and markers
Early identification of monochorionic twin pregnancies at 
increased risk of TTTS would assist patient counselling, 
follow‑up in a fetal medicine centre and institution for timely 
treatment. Unquestionably, timely treatment of TTTS might 
improve the outcome by preventing PPROM and/or cervical 
shortening, important risk factors for preterm birth.[48‑50] 
Some markers for the early identification of monochorionic 
twins with high risk for the development of TTTS include 
nuchal translucency (NT), folding of the intertwin membrane 
and crown rump length (CRL).
An increased nuchal translucency of >95th percentile in at 
least one fetus during 11–14 weeks examination occurs in 13% 
of monochorionic twins. This finding is a marker for TTTS as 
well as for other conditions such as chromosomal anomalies, 
cardiac defects and a myriad of genetic syndromes.[16] Folding 
of the intertwin membrane at 15–17 weeks is another sign 
for the prediction of TTTS.[50] It reflects the presence of 
oliguria and a reduced amniotic fluid in the sac of the donor. 
CRL difference between the twins of ≥6 mm is predictive 
of diagnosis of TTTS.[16] A velamentous or marginal cord 
insertion has been demonstrated by Fries et al.[51] to indicate 
risk for the development of TTTS.
Fetal risks
TTTS that is not recognized early and treated accordingly can 
lead to nearly 100% mortality. However, improvement in prenatal 
and neonatal care has reduced mortality to approximately 
60%. Some complications include abortion, extreme preterm 
birth, hydramnios and fetal death from cardiac failure in the 
recipient and poor perfusion in the donor. In addition, chronic 
haemodynamic imbalance leads to substantial cerebral and 
cardiac sequelae in survivors. Both recipient and donor are at 
risk for antenatally acquired cerebral lesions. In donor twins, 
hypovolemia, hypotension and anaemia may induce cerebral 
hypoxia and brain damage. Conversely, hyperviscosity and 
cardiac failure in the donor may impair cerebral perfusion. 
Hence, the reported incidences of cerebral palsy and major 
neurological deficiencies in TTTS are 6–23%.[52,53]
Management options
Several treatment options utilized in the management of TTTS 
include serial amniodrainage, fetoscopic laser coagulation, 
septostomy and selective feticide.[54‑56] Amniodrainage is a 
palliative procedure and involves the iatrogenic reduction 
of the volume of amniotic fluid. It is useful in the treatment 
of mild cases of TTTS such as stages I and II by prolonging 
the pregnancy and improving the fetal condition through the 
reduction of the intrauterine pressure.
Fetoscopic laser coagulation (fetoscopic laser occlusion of 
chorioangiopagus vessels, FLOC) is superior to amniodrainage 
in the management of all stages of TTTS because the 
procedure permits the disruption of the vascular connections 
between the twins, thereby terminating the circulation of 
blood from one twin to the other.[55‑58] Flimsy or minimal 
fetofetal vascular connections, which may be primary 
antenatally or secondary to FLOC, can result in TAPS that 
is treatable postnatally by blood transfusion of donor twin 
with blood obtained from the recipient twin.[59] Despite 
this uncommon complication, laser coagulation is the 
recommended firstline treatment for TTTS because it leads 
to better survival rates and neurological outcome.[54,60]
Septostomy is still being used in the treatment of some cases 
of TTTS and involves the dissolution of the amnion between 
the donor and recipient twins leading to a single sac, thus 
reducing pressure surrounding the babies. Septostomy does 
not possess survival advantage over amniodrainage or laser 
coagulation. Selective feticide is achieved by cord occlusion 
but does not arrest the transfusion of blood from one twin to 
the other. It is the treatment of choice in cases associated with 
discordant anomalies and imminent fetal death, as well as in 
pregnancies in which laser coagulation is difficult because full 
inspection of the vascular equator is technically not feasible.
Conclusion
At present, there is paucity of published literature on the 
subject of transfusion syndromes in monochorionic multiplets 
in sub‑Saharan Africa and Nigeria in particular. Setting 
up appropriate perinatology units and collaboration with 
established centres in Europe, North America and Asia will 
facilitate growth and success of such units. The extensive work 
and volume of publications from the North American Fetal 
Therapy Network (NAFTNet), the Eurofoetus consortium and 
the USFetus organisation in the last decade[61] show the power 
of collaboration with the success achieved on this subject.
Financial support and sponsorship 
Nil.
Osaghae and Unuigbe: Transfusion syndromes in twins
141Tropical Journal of Obstetrics and Gynaecology / May-Aug 2016 / Volume 33 / Issue 2
Conflicts of interest
There are no conflicts of interest.
References
1. Skupski DW. TTTS: Where did we come from? Distant History. In: 
Skupsi DW, editor. Twin-To-Twin Transfusion Syndrome. 1st ed. 
New Delhi, London, Philadelphia, Panama: Jaypee Brothers Medical 
Publishers (P) Ltd; 2013. p. 3-15.
2. Scher A, Petterson B, Blair E, Ellenberg JH, Grether JK, Haan E, 
et al. The risk of mortality or cerebral palsy in twins: A collaborative 
population based study. Paediatr Res 2002;52:671-81.
3. Lewi L, Jani J, Blickstein I, Huber A, Gucciardo L, Van Mieghem T, 
et al. The outcome of monochorionic diamniotic twin gestations in the 
era of invasive fetal therapy: A prospective cohort study. Am J Obstet 
Gynecol 2008;199:514.
4. Lewi L, Gucciardo L, Van Mieghem T, de Koninck P, Beck V, Medek H, 
et al. Monochorionic diamniotic twin pregnancies: Natural history and 
risk stratification. Fetal Diagn Ther 2010;27:121‑33.
5. Glinianaia SV, Pharaoh PO, Wright C, Rankin JM; Northern Region 
Perinatal Mortality Survey Steering Group. Fetal or infant death in twin 
pregnancy: Neurodevelopmental consequence for the survivor. Arch Dis 
Child Fetal Neonatal Ed 2002;86:F9‑15.
6. Blickstein I. Do multiple gestations raise the risk of cerebral palsy? Clin 
Perinatol 2004;31:395-408.
7. Ugwu OR, Egri Okwaji MT. Perinatology in the Tropics. In: Azubuike JC, 
Nkaginieme KE. editord. Paediatrics and Child Health in a Tropical 
Region. 2nd ed. University of Port Harcourt Press; 2007. p. 157-60.
8. Osaghae DO, Sule G, Ogieva R. Admissions and outcome of newborns 
in Benin City. Niger Hosp Pract 2013;11:45-9.
9. UNFPA. Trends in Maternal Mortality (http//www.unfpa.org/
maternal-health) Updated November, 2015.
10. Unuigbe, JA, Orhue AA, Oronsaye AU. Maternal mortality at the 
University of Benin Teaching Hospital, Benin-City, Nigeria., 1973-1985. 
Trop J Obstet Gynaecol 1988;1:13-8.
11. Nylander PP. The frequency of twinning in a rural community in Western 
Nigeria. Ann Hum Genet 1969;33:41-4.
12. Nylander PP. Twinning in Nigeria. Acta Genet Med Gemellol 
1970;19:457-64.
13. Nylander PP. The incidence of triplets and higher multiple births in 
some rural and urban populations in Western Nigeria. Ann Hum Gen 
1971;34:409-15.
14. Matte U, Le Roux MG, Benichou B, Moisan J, Giuglani R. Study on 
possible increase in twinning rate at a small village in South Brazil. Acta 
Genet Med Gemellol 1996;45:431-7.
15. Ikechebelu JI. Assisted Reproductive Technique (ART): The state of the 
Art in Nigeria. Int J Med Health Dev 2003;8:1-6.
16. Lewi L, Deprest J. Fetal problems in multiple pregnancies. In: James D, 
Steer PJ, Weiner CP, Gonik B, Crowther CA, Robson SC, editors. High 
Risk Pregnancy: Management Options. 4th ed. St Louis, MO 63403: 
Elsevier Saunders; 2011. p. 405-36.
17. Bulmer MG. The Biology of Twinning in Man. Clarendon Oxford; 1970.
18. Derom C, Derom R. The East Flanders Prospective Twin Survey. In: 
Blickstein I, Keith LG, editors. Multiple Pregnancy. 2nd ed. London: 
Taylor & Francis; 2005. p. 39‑47.
19. Alikani M, Cekleniak NA, Walters E, Cohen J. Monozygotic twinning 
following assisted conception: An analysis of 81 consecutive cases. 
Hum Reprod 2003;18:1937-43.
20. Chow JS, Benson CB, Racowsky C, Doubilet PM, Ginsburg E. 
Frequency of a monochorionic pair in multiple gestations: Relationship 
to mode of conception. J Ultrasound Med 2001;20:757-60.
21. De Catte L, Camus M, Foulon W. Monochorionic high‑order multiple 
pregnancies and multifetal pregnancy reduction. Obstet Gynecol 
2002;100:561-6.
22. Levene MI. Fetal physiology, assessment of fetal well‑being and 
adaptation to extra-uterine life. In: Levene IM, Tudehope D, Thearle MJ, 
editors. Essentials of Neonatal Medicine. 2nd ed. Blackwell science; 
1996. p. 6-16.
23. Lewi L, Van Schoubroeck D, Gratacós E, Witters I, Timmerman D, 
Deprest J. Monochorionic diamniotic twins: Complications and 
management options. Curr Opin Obstet Gynecol. 2003; 15: 177-194
24. Fisk NM, Duncombe GJ, Sullivan MH. The basic and clinical of 
twin-twin transfusion syndrome. Placenta 2009;30:379-90.
25. Kaufmann P, Mayhew TM, Charnock-Jones DS. Aspects of human 
fetoplacental vasculogenesis and angiogenesis. Changes during normal 
pregnancy. Placenta 2004;25:114-26.
26. Diehl W, Hecher K, Zikulnig L, Vetter M, Hackelöer BJ. Placental 
vascular anastomoses visualized during fetoscopic laser surgery 
in severe mid-trimester twin–twin transfusion syndrome. Placenta 
2001;22:876-81.
27. Arabian B, Baschat A. Colour injection and digital angiography. In: 
Skupski DW, editor. Twin-To-Twin Transfusion Syndrome. 1st ed. 
London: Jaypee Brothers Medical Publishers; 2013. p. 45-56.
28. Senat MV, Deprest J, Boulvain M, Paupe A, Winer N, Ville Y. Endoscopic 
laser surgery versus serial amnioreduction for severe twin-to-twin 
transfusion syndrome. N Engl J Med 2004;351:136-44.
29. Rossi AC, D’Addario V. The efficacy of Quintero staging system to 
assess the severity of twin-twin transfusion syndrome treated with 
laser therapy: A systematic review with meta-analysis. Am J Perinatol 
2009;26:537-44.
30. Delia JE, Fisk N, Hecher K, Machin G, Nicolaides K, Hyett J, et al. 
Twin-to-twin transfusion syndrome – debates on etiology, natural history 
and management. Ultrasound Obstet Gynecol 2000;16:210-3.
31. Xueju W, Pengbo Y, Ying W, Yangyu Z, Yuan W. Placental characteristics 
of monochorionic twin pregnancy complicated with selective fetal 
growth restriction (Chinese). Chin J Perinat Med 2015;18:260-5.
32. Acosta-Rojas R1, Becker J, Munoz-Abellana B, Ruiz C, Carreras E, 
Gratacos E, et al. Catalunya and Balears Monochorionic Network: Twin 
chorionicity and the risk of adverse perinatal outcome. Int J Gynecol 
Obstet 2007;96:98-102.
33. Lewi L, Jani J, Blickstein, Huber A, Gucciardo L, Van Mieghem T, et al. 
The outcome of monochorionic diamniotic twin gestations in the era of 
invasive fetal therapy: A prospective cohort study. Am J Obstet Gynecol 
2008;199:514.
34. Denbow ML, Cox P, Taylor M, Hammal DM, Fisk NM. Placental 
angioarchitecture in monochorionic twin pregnancies: Relationship to 
fetal growth, feto-fetal transfusion syndrome, and pregnancy outcome. 
Am J Obstet Gynecol 2000;182:417-4.
35. Lewi L, Cannie M, Bliekstein I, Jani J, Huber A, Hecher K, et al. 
Placental sharing, birthweight discordance, and vascular anastomoses 
in monochorionic diamniotic twin placentas. Am J Obstet Gynecol 
2007;197:587.
36. Bermudez C, Becerra CH, Bornick PW, Allen MH, Arroyo J, 
Quintero RA. Placental types and twin‑twin transfusion syndrome. Am 
J Obstet Gynecol 2002;187:489-94.
37. Quintero RA, Morales WJ, Allen MH, Bornick PW, Johnson PK, Kruger M. 
Staging of twin-twin transfusion syndrome. J Perinatol 1999;19:550-5.
38. Xueju W, Yuan W, Pengbo Y, Yangyu Z. Placental characteristics 
of twin-to-twin transfusion syndrome (Chinese). Natl Med J China 
2015;95:1323-7.
39. Obladen M. Unequal but monozygous: A history of twin-twin transfusion 
syndrome. J Perinat Med 2010;38:121-8.
40. Bajoria R, Ward S, Sooranna SR. Erythropoietin in monochorionic twin 
pregnancies in relation to twin-twin transfusion syndrome. Hum Reprod 
2001;16:574-80.
41. Bajoria R, Lazda EJ, Ward S, Sooranna S. Iron metabolism in 
monochorionic twin pregnancies in relation to twin-twin transfusion 
syndrome Hum Reprod 2001;16:567-73.
Osaghae and Unuigbe: Transfusion syndromes in twins
142 Tropical Journal of Obstetrics and Gynaecology / May-Aug 2016 / Volume 33 / Issue 2
42. Bajoria R, Gibson MJ, Ward S, Sooranna SR, Neilson JP, Westwood M. 
Placental regulation of insulin-like growth factor axis in monochorionic 
twins with chronic twin-twin transfusion syndrome. J Clin Endocrinol 
Metab 2001;86:3150-5.
43. Sooranna SR, Ward S, Bojaria R. Discordant fetal leptin levels in 
monochorionic twins with chronic midtrimester twin-twin transfusion 
syndrome. Placenta 2001;22:392-8.
44. Bajoria R, Ward S, Chatterjee R. Natriuretic peptides in the pathogenesis 
of cardiac dysfunction in the recipient fetus of twin-to-twin transfusion 
syndrome. Am J Obstet Gynecol 2002;186:121-7.
45. Mahieu-Caputo D, Meulemans A, Martinovic J, Lacoste M, Cai Y, 
Narcy F, et al. Twin-to-twin teransfusion syndrome. Role of the fetal 
renin-angiotensin system. Am J Pathol 2001;156:629-36.
46. Kilby MD, Platt C, Whittle MJ, Oxley J, Lindop GB. Renin gene 
expression in fetal kidneys of pregnancies complicated by twin-twin 
transfusion syndrome. Pediatr Dev Pathol 2001;4:175-9.
47. Galea P, Bargye O, Wee L, Jain V, Sullivan M, Fisk NM. The placenta 
contributes to activation of the renin angiotensin system in twin-twin 
transfusion syndrome. Placenta 2008;29:734-42.
48. de Lia JE, Carr MH. Pregnancy loss after successful laser surgery for 
previable twin-twin transfusion syndrome (letter). Am J Obstet Gynecol 
2002;187:517-8.
49. Robyr R, Boulvain M, Lewi L, Huber A, Hecher K, Deprest J, et al. 
Cervical length as a prognostic factor for preterm delivery in twin-twin 
transfusion syndrome treated by fetoscopic laser coagulation of chorionic 
plate anastomoses. Ultrasound Obstet Gynecol 2005;25:37-41.
50. Sebire NJ, Souka A, Skentou H, Geerts L, Nicolaides KH. Early 
prediction of severe twin-to-twin transfusion syndrome. Hum Reprod 
2010;15:2008-10.
51. Fries MH, Goldstein RB, Kilpatrick SJ, Golbus MS, Callen PW, 
Filly RA. The role of velamentous cord insertion in the aetiology of 
twin-twin transfusion syndrome. Obstet Gynecol 1993;81:569-74.
52. Lopriore E, van Wezel-Meijler G, Middeldorp JM, Sueters M, 
Vandenbussche FP, Walther FJ. et al. Incidence, origin and character 
of cerebral injury in twin-to-twin transfusion syndrome treated with 
fetoscopic laser surgery. Am J Obstet Gynecol 2006;194:1215-20.
53. Bejar R, Vigliocco G, Gramajo H, Solana C, Benirschke K, Berry C, 
et al. Antenatal origins of neurological damage in newborn infants in 
multiple gestations. Am J Obstet Gynecol 1990;162:1230-6.
54. Senat MV, Deprest J, Boulvain M, Paupe A, Winer N, Ville Y. Endoscopic 
laser surgery versus serial amnioreduction for severe twin-to-twin 
transfusion syndrome. N Engl J Med 2004;351:136-44.
55. Lopriore E, Nagel HT, Vandenbussche FP, Walther FJ. Long‑term 
neurodevelopmental outcome in twin-to-twin transfusion syndrome. 
Am J Obstet Gynecol 2003;189:1314-9.
56. van Gemert MJ, Umur A, Tijssen JG, Ross MG. Twin-twin transfuision 
syndrome: Etiology, severity and rational management. Curr Opin Obstet 
Gynecol 2001;13:193-206.
57. Skupski DW, Gurushanthaiah K, Chasen S. The effect of treatment of 
twin-twin transfusion syndrome on the diagnosis to delivery interval. 
Twin Res 2002;5:1-4.
58. Graef C, Ellienrieder B, Hecher K, Hackeloer BJ, Huber A, Bartmann P. 
Long-term neurodevelopmental outcome of 167 children after 
intrauterine laser treatment for severe twin-twin transfusion syndrome. 
Am J Obstet Gynecol 2006;194:303-8.
59. Osaghae DO, Unuigbe JA. Twin Anemia Polycythemia Sequence (TAPS): 
Postnatal correction of severe anemia in donor twin by transfusion of 
blood evacuated from the recipient polycythemic twin. Trop J Obstet 
Gynaecol April; 33:113-9.
60. Xueju W, Guangwu X, Yuan W, Pengbo Y, Yangyu Z. Clinical 
effect of fetoscopic laser occlusion of chorioangiopagus vessels for 
twin-to-twin transfusion syndrome (Chinese). Chin J Obstet Gynecol 
2014;49:886-93.
61. Johnson MP; NAFTNet. The North American Fetal Therapy 
Network (NAFTNet): A new approach to collaborative research in fetal 
diagnosis and therapy. Semin Fetal Neonatal Med 2010;15:52‑7.
